TG Therapeutics Archives -

TG Therapeutics has completed its rolling FDA filing for its U2 combination therapy consisting of the antibody ublituximab

TG Therapeutics completes FDA filing for Roche challenger in CLL

https://pharmaphorum.com/news/tg-therapeutics-completes-fda-filing-for-roche-challenger-in-cll/

Bristol-Myers Squibb finally has FDA approval for its CAR-T therapy liso-cel, which has been cleared by the US

BMS finally gets FDA OK for liso-cel, sets $410k launch price

https://pharmaphorum.com/news/bms-finally-gets-fda-ok-for-liso-cel-sets-410k-launch-price/

TG Therapeutics provided one of the highlights of the American Society of Hematology (ASH) conference earlier this month

TG Therapeutics raises funds for cancer combination drug

https://pharmaphorum.com/news/tg-therapeutics-set-for-upsized-ipo-to-develop-cancer-combination-drug/

US biotech TG Therapeutics has begun a rolling filing with the FDA for its combination therapy for chronic

TG Therapeutics challenges Roche with FDA filing for CLL drug

https://pharmaphorum.com/news/tg-therapeutics-challenges-roche-with-fda-filing-for-cll-drug/

The FDA has accepted TG Therapeutics’ filing for its lymphoma drug umbralisib, which if approved could compete against

FDA to decide on TG Therapeutics’ lymphoma drug early next year

https://pharmaphorum.com/news/fda-to-decide-on-tg-therapeutics-lymphoma-drug-early-next-year/

TG Therapeutics (TG) has suffered a setback in its blood cancer drug trial, as the data available was

TG Therapeutics cancer trial setback sends shares tumbling

https://pharmaphorum.com/news/tg-therapeutics-cancer-trial-setback-sends-shares-tumbling/

TG Therapeutics